Omsan (Ethinylestradiol, Levonorgestrel)

Ethinylestradiol, the active ingredient in Omsan, is a combined oral contraceptive presented as an oral tablet for oral use. It prevents pregnancy by providing reliable contraceptive protection for women of reproductive age. GNH USA supplies Omsan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omsan is a combined oral contraceptive that acts on the hormonal regulation of the menstrual cycle to prevent pregnancy. - Prevention of pregnancy: provides reliable contraceptive protection for women of reproductive age. - Menstrual cycle regulation: helps achieve more regular menstrual bleeding patterns when prescribed for this purpose.

Common Side Effects: - Nausea: mild stomach upset that often resolves with continued use. - Headache: transient tension‑type or migraine‑type headaches. - Breast tenderness: temporary swelling or discomfort. - Spotting or breakthrough bleeding: irregular light bleeding between periods. - Mood changes: mild irritability or emotional fluctuations. - Weight fluctuation: slight increase or decrease in body weight.

Serious or Rare Side Effects: - Deep vein thrombosis: swelling, pain, or redness in a limb. - Pulmonary embolism: sudden shortness of breath or chest pain. - Stroke: sudden weakness, speech difficulty, or facial droop. - Liver dysfunction: jaundice, dark urine, or abdominal pain. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Hypertension: persistent high blood pressure readings.

Before starting Omsan, consider the following precautions: - Smoking: avoid smoking, especially if over 35 years old, due to increased cardiovascular risk. - Cardiovascular disease: assess history of heart disease, stroke, or clotting disorders. - Liver disease: evaluate hepatic function as metabolism may be impaired. - Migraine with aura: discuss increased stroke risk with a healthcare professional. - Breast cancer: avoid use if a current or past diagnosis of estrogen‑sensitive cancer. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Omsan may interact with several medicines that affect its efficacy or safety. Major Interactions (Avoid): - Antiepileptic drugs (e.g., carbamazepine, phenytoin): may reduce contraceptive effectiveness. - Rifampicin and other strong enzyme inducers: can lower hormone levels, increasing pregnancy risk. - Certain HIV protease inhibitors: may increase hormone concentrations, raising side‑effect risk. Moderate Interactions (Monitor Closely): - Antifungal agents (e.g., ketoconazole): may modestly increase hormone levels. - St. John’s wort: may slightly reduce contraceptive efficacy. - Antibiotics (e.g., tetracycline): generally have minimal impact but monitor for breakthrough bleeding.